Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema

Tom Bowen, Marco Cicardi, H. Farkas, Konrad Bork, Wolfhart Kreuz, Lorenza Zingale, L. Varga, Inmaculada Martinez-Saguer, Emel Aygören-Pürsün, Karen Binkley, Bruce Zuraw, Alvin Davis, Jacques Hebert, Bruce Ritchie, Jeanne Burnham, Anthony Castaldo, Alejandra Menendez, Istvan Nagy, G. Harmat, Christoph Bucher & 18 others Gina Lacuesta, Andrew Issekutz, Richard Warrington, William Yang, John Dean, Amin Kanani, Donald Stark, Christine McCusker, Eric Wagner, Georges Etienne Rivard, Eric Leith, Ellie Tsai, Michael MacSween, John Lyanga, Bazir Serushago, Art Leznoff, Susan Waserman, Jean De Serres

Research output: Contribution to journalArticle

179 Citations (Scopus)

Abstract

C1 inhibitor deficiency (hereditary angioedema [HAE]) is a rare disorder for which there is a lack of consensus concerning diagnosis, therapy, and management, particularly in Canada. European initiatives have driven the approach to managing HAE with 3 C1-INH Deficiency Workshops held every 2 years in Hungary starting in 1999, with the third Workshop having recently been held in May 2003. The European Contact Board has established a European HAE Registry that will hopefully advance our knowledge of this disorder. The Canadian Hereditary Angioedema Society/Socit d'Angiodème Hrditaire du Canada organized a Canadian International Consensus Conference held in Toronto, Ontario, Canada, on October 24 to 26, 2003, to foster consensus between major European and North American HAE treatment centers. Papers were presented by investigators from Europe and North America, and this consensus algorithm approach was discussed. There is a paucity of double-blind placebo-controlled trials in the treatment of HAE, making levels of evidence to support the algorithm less than optimal. Enclosed is the consensus algorithm approach recommended for the diagnosis, therapy, and management of HAE and agreed to by the authors of this article. This document is only a consensus algorithm approach and requires validation. As such, participants agreed to make this a living 2003 algorithm (ie, a work in progress) and agreed to review its content at future international HAE meetings. The consensus, however, has strength in that it was arrived at by the meeting of patient-care providers along with patient group representatives and individual patients reviewing information available to date and reaching agreement on how to approach the diagnosis, therapy, and management of HAE circa 2003. Hopefully evidence to support approaches to the management of HAE will approach the level of meta-analysis of randomized controlled trials in the near future.

Original languageEnglish
Pages (from-to)629-637
Number of pages9
JournalJournal of Allergy and Clinical Immunology
Volume114
Issue number3
DOIs
Publication statusPublished - Sep 2004

Fingerprint

Hereditary Angioedemas
Therapeutics
Canada
Patient Advocacy
Education
Hungary
Ontario
North America
Registries
Meta-Analysis
Patient Care
Randomized Controlled Trials

Keywords

  • C1 inhibitor
  • C1 inhibitor deficiency
  • consensus
  • Hereditary angioedema

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. / Bowen, Tom; Cicardi, Marco; Farkas, H.; Bork, Konrad; Kreuz, Wolfhart; Zingale, Lorenza; Varga, L.; Martinez-Saguer, Inmaculada; Aygören-Pürsün, Emel; Binkley, Karen; Zuraw, Bruce; Davis, Alvin; Hebert, Jacques; Ritchie, Bruce; Burnham, Jeanne; Castaldo, Anthony; Menendez, Alejandra; Nagy, Istvan; Harmat, G.; Bucher, Christoph; Lacuesta, Gina; Issekutz, Andrew; Warrington, Richard; Yang, William; Dean, John; Kanani, Amin; Stark, Donald; McCusker, Christine; Wagner, Eric; Rivard, Georges Etienne; Leith, Eric; Tsai, Ellie; MacSween, Michael; Lyanga, John; Serushago, Bazir; Leznoff, Art; Waserman, Susan; De Serres, Jean.

In: Journal of Allergy and Clinical Immunology, Vol. 114, No. 3, 09.2004, p. 629-637.

Research output: Contribution to journalArticle

Bowen, T, Cicardi, M, Farkas, H, Bork, K, Kreuz, W, Zingale, L, Varga, L, Martinez-Saguer, I, Aygören-Pürsün, E, Binkley, K, Zuraw, B, Davis, A, Hebert, J, Ritchie, B, Burnham, J, Castaldo, A, Menendez, A, Nagy, I, Harmat, G, Bucher, C, Lacuesta, G, Issekutz, A, Warrington, R, Yang, W, Dean, J, Kanani, A, Stark, D, McCusker, C, Wagner, E, Rivard, GE, Leith, E, Tsai, E, MacSween, M, Lyanga, J, Serushago, B, Leznoff, A, Waserman, S & De Serres, J 2004, 'Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema', Journal of Allergy and Clinical Immunology, vol. 114, no. 3, pp. 629-637. https://doi.org/10.1016/j.jaci.2004.06.043
Bowen, Tom ; Cicardi, Marco ; Farkas, H. ; Bork, Konrad ; Kreuz, Wolfhart ; Zingale, Lorenza ; Varga, L. ; Martinez-Saguer, Inmaculada ; Aygören-Pürsün, Emel ; Binkley, Karen ; Zuraw, Bruce ; Davis, Alvin ; Hebert, Jacques ; Ritchie, Bruce ; Burnham, Jeanne ; Castaldo, Anthony ; Menendez, Alejandra ; Nagy, Istvan ; Harmat, G. ; Bucher, Christoph ; Lacuesta, Gina ; Issekutz, Andrew ; Warrington, Richard ; Yang, William ; Dean, John ; Kanani, Amin ; Stark, Donald ; McCusker, Christine ; Wagner, Eric ; Rivard, Georges Etienne ; Leith, Eric ; Tsai, Ellie ; MacSween, Michael ; Lyanga, John ; Serushago, Bazir ; Leznoff, Art ; Waserman, Susan ; De Serres, Jean. / Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. In: Journal of Allergy and Clinical Immunology. 2004 ; Vol. 114, No. 3. pp. 629-637.
@article{5b2f2db6168a4f9a8ec5ef323b10f0cf,
title = "Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema",
abstract = "C1 inhibitor deficiency (hereditary angioedema [HAE]) is a rare disorder for which there is a lack of consensus concerning diagnosis, therapy, and management, particularly in Canada. European initiatives have driven the approach to managing HAE with 3 C1-INH Deficiency Workshops held every 2 years in Hungary starting in 1999, with the third Workshop having recently been held in May 2003. The European Contact Board has established a European HAE Registry that will hopefully advance our knowledge of this disorder. The Canadian Hereditary Angioedema Society/Socit d'Angiod{\`e}me Hrditaire du Canada organized a Canadian International Consensus Conference held in Toronto, Ontario, Canada, on October 24 to 26, 2003, to foster consensus between major European and North American HAE treatment centers. Papers were presented by investigators from Europe and North America, and this consensus algorithm approach was discussed. There is a paucity of double-blind placebo-controlled trials in the treatment of HAE, making levels of evidence to support the algorithm less than optimal. Enclosed is the consensus algorithm approach recommended for the diagnosis, therapy, and management of HAE and agreed to by the authors of this article. This document is only a consensus algorithm approach and requires validation. As such, participants agreed to make this a living 2003 algorithm (ie, a work in progress) and agreed to review its content at future international HAE meetings. The consensus, however, has strength in that it was arrived at by the meeting of patient-care providers along with patient group representatives and individual patients reviewing information available to date and reaching agreement on how to approach the diagnosis, therapy, and management of HAE circa 2003. Hopefully evidence to support approaches to the management of HAE will approach the level of meta-analysis of randomized controlled trials in the near future.",
keywords = "C1 inhibitor, C1 inhibitor deficiency, consensus, Hereditary angioedema",
author = "Tom Bowen and Marco Cicardi and H. Farkas and Konrad Bork and Wolfhart Kreuz and Lorenza Zingale and L. Varga and Inmaculada Martinez-Saguer and Emel Ayg{\"o}ren-P{\"u}rs{\"u}n and Karen Binkley and Bruce Zuraw and Alvin Davis and Jacques Hebert and Bruce Ritchie and Jeanne Burnham and Anthony Castaldo and Alejandra Menendez and Istvan Nagy and G. Harmat and Christoph Bucher and Gina Lacuesta and Andrew Issekutz and Richard Warrington and William Yang and John Dean and Amin Kanani and Donald Stark and Christine McCusker and Eric Wagner and Rivard, {Georges Etienne} and Eric Leith and Ellie Tsai and Michael MacSween and John Lyanga and Bazir Serushago and Art Leznoff and Susan Waserman and {De Serres}, Jean",
year = "2004",
month = "9",
doi = "10.1016/j.jaci.2004.06.043",
language = "English",
volume = "114",
pages = "629--637",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema

AU - Bowen, Tom

AU - Cicardi, Marco

AU - Farkas, H.

AU - Bork, Konrad

AU - Kreuz, Wolfhart

AU - Zingale, Lorenza

AU - Varga, L.

AU - Martinez-Saguer, Inmaculada

AU - Aygören-Pürsün, Emel

AU - Binkley, Karen

AU - Zuraw, Bruce

AU - Davis, Alvin

AU - Hebert, Jacques

AU - Ritchie, Bruce

AU - Burnham, Jeanne

AU - Castaldo, Anthony

AU - Menendez, Alejandra

AU - Nagy, Istvan

AU - Harmat, G.

AU - Bucher, Christoph

AU - Lacuesta, Gina

AU - Issekutz, Andrew

AU - Warrington, Richard

AU - Yang, William

AU - Dean, John

AU - Kanani, Amin

AU - Stark, Donald

AU - McCusker, Christine

AU - Wagner, Eric

AU - Rivard, Georges Etienne

AU - Leith, Eric

AU - Tsai, Ellie

AU - MacSween, Michael

AU - Lyanga, John

AU - Serushago, Bazir

AU - Leznoff, Art

AU - Waserman, Susan

AU - De Serres, Jean

PY - 2004/9

Y1 - 2004/9

N2 - C1 inhibitor deficiency (hereditary angioedema [HAE]) is a rare disorder for which there is a lack of consensus concerning diagnosis, therapy, and management, particularly in Canada. European initiatives have driven the approach to managing HAE with 3 C1-INH Deficiency Workshops held every 2 years in Hungary starting in 1999, with the third Workshop having recently been held in May 2003. The European Contact Board has established a European HAE Registry that will hopefully advance our knowledge of this disorder. The Canadian Hereditary Angioedema Society/Socit d'Angiodème Hrditaire du Canada organized a Canadian International Consensus Conference held in Toronto, Ontario, Canada, on October 24 to 26, 2003, to foster consensus between major European and North American HAE treatment centers. Papers were presented by investigators from Europe and North America, and this consensus algorithm approach was discussed. There is a paucity of double-blind placebo-controlled trials in the treatment of HAE, making levels of evidence to support the algorithm less than optimal. Enclosed is the consensus algorithm approach recommended for the diagnosis, therapy, and management of HAE and agreed to by the authors of this article. This document is only a consensus algorithm approach and requires validation. As such, participants agreed to make this a living 2003 algorithm (ie, a work in progress) and agreed to review its content at future international HAE meetings. The consensus, however, has strength in that it was arrived at by the meeting of patient-care providers along with patient group representatives and individual patients reviewing information available to date and reaching agreement on how to approach the diagnosis, therapy, and management of HAE circa 2003. Hopefully evidence to support approaches to the management of HAE will approach the level of meta-analysis of randomized controlled trials in the near future.

AB - C1 inhibitor deficiency (hereditary angioedema [HAE]) is a rare disorder for which there is a lack of consensus concerning diagnosis, therapy, and management, particularly in Canada. European initiatives have driven the approach to managing HAE with 3 C1-INH Deficiency Workshops held every 2 years in Hungary starting in 1999, with the third Workshop having recently been held in May 2003. The European Contact Board has established a European HAE Registry that will hopefully advance our knowledge of this disorder. The Canadian Hereditary Angioedema Society/Socit d'Angiodème Hrditaire du Canada organized a Canadian International Consensus Conference held in Toronto, Ontario, Canada, on October 24 to 26, 2003, to foster consensus between major European and North American HAE treatment centers. Papers were presented by investigators from Europe and North America, and this consensus algorithm approach was discussed. There is a paucity of double-blind placebo-controlled trials in the treatment of HAE, making levels of evidence to support the algorithm less than optimal. Enclosed is the consensus algorithm approach recommended for the diagnosis, therapy, and management of HAE and agreed to by the authors of this article. This document is only a consensus algorithm approach and requires validation. As such, participants agreed to make this a living 2003 algorithm (ie, a work in progress) and agreed to review its content at future international HAE meetings. The consensus, however, has strength in that it was arrived at by the meeting of patient-care providers along with patient group representatives and individual patients reviewing information available to date and reaching agreement on how to approach the diagnosis, therapy, and management of HAE circa 2003. Hopefully evidence to support approaches to the management of HAE will approach the level of meta-analysis of randomized controlled trials in the near future.

KW - C1 inhibitor

KW - C1 inhibitor deficiency

KW - consensus

KW - Hereditary angioedema

UR - http://www.scopus.com/inward/record.url?scp=4444347650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444347650&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2004.06.043

DO - 10.1016/j.jaci.2004.06.043

M3 - Article

VL - 114

SP - 629

EP - 637

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 3

ER -